This compound is a nucleoside phosphoramidite building block used primarily in pharmaceutical and biotechnology research. It features a complex, highly modified nucleoside structure with multiple aromatic rings and a phosphoramidite group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1391913-24-8
DMT-2'-O-TBDMS-G(dmf)-CE-phosphoramidite
research compound
DMF-dG Phosphoramidite
pharmaceutical intermediate
N'-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-tetrahydrofuran-2-yl]purin-6-yl]-N,N-dimethyl-acetamidine
pharmaceutical intermediate
Tert-butyl (5R)-5-amino-3,3-difluoropiperidine-1-carboxylate
pharmaceutical intermediate
Micafungin Impurity H
pharmaceutical intermediate
Nalpha-Fmoc-L-lysine hydrochloride
pharmaceutical intermediate
2-Methoxy-2-oxoethyl [2-(2,6-dichloroanilino)phenyl]acetate
pharmaceutical intermediate
5'-O-DMT-N2-DMF-dG
pharmaceutical intermediate
N'-[9-[(2R,3S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
BUKKJOTXODUNQK-NTXSMOKRSA-N
CC(C)N(C(C)C)P(OCCC#N)OC1[C@H](O[C@H]([C@H]1F)N2C=NC3=C2N=C(NC3=O)/N=C/N(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC
—